Our recommendations help practitioners and commissioners get the best care to people, fast, while ensuring value for the taxpayer.
Over 14,000 people to benefit after NICE published final guidance recommending abaloparatide as an option for treating osteoporosis after menopause, if there is a very high risk of fracture.
NICE's deputy chief executive, Jonathan Benger, talks about our new approach to prioritisation.
Simon Denegri discusses NICE’s commitment to involving the public voice in its work and decisions.
Daiichi Sankyo and partner company AstraZeneca have been unwilling to offer a price that would enable NICE to recommend Enhertu as cost effective for the NHS in final guidance published today.
Best practice resources for practitioners and commissioners.
Useful sources of information and advice for healthcare professionals, patients, parents and carers.
Summaries of evidence and advice on common health topics (CKS)
Join us in our mission to improve the quality of health and social care services. Our committees develop and update our guidance.
They meet over several months and their work is vital in forming our recommendations.
Being a committee member puts you at the heart of our work and helps us make sure that our guidance is relevant to the people that matter.
